|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Patients with impaired pulmonary function are at increased risk for the development of postoperative complications. Recently exercise testing and predicted postoperative (ppo) function have gained
increasing importance in the evaluation of lung resection candidates. We prospectively evaluated an
algorithm for the preoperative functional evaluation that was developed at our institution. This algorithm incorporated the cardiac history including an electrocardiogram (ECG), and the three parameters FEV1, diffusing capacity of the lungs for carbon monoxide (DLCO), and maximal oxygen uptake
(
O2max), as well as their respective ppo values (FEV1-ppo, DLCO-ppo, and
O2max-ppo) calculated
based on radionuclide perfusion scans. A consecutive group of 137 patients (mean age 62 yr; range
23 to 81; 102 males, 35 females) with clinically resectable lesions underwent assessment according to
our algorithm. Five patients were deemed functionally inoperable, 132 passed the algorithm and underwent pulmonary resections with standard thoracotomy: 9 segmental or wedge resections, 85 lobectomies (inclusive 3 bilobectomies), and 38 pneumonectomies. All patients were extubated
within 24 h. The mean stay in the ICU was 1.4 (± 1.8) d, and the mean hospital stay was 14.6 (± 5) d.
Postoperative complications (within 30 d) occurred in 15 patients (11%), of whom two died (overall
mortality rate 1.5%). In comparison to our previous series this meant a 50% reduction in complications whereas the percentage of inoperable patients remained unchanged (4% now, 5% before). We
conclude that adherence to our algorithm resulted in a very low complication rate (morbidity and
mortality), and excluded more rigorous patient selection as a bias for the improved results.
| |
INTRODUCTION |
|---|
|
|
|---|
Patients with lung cancer who undergo evaluation for lung resection are usually smokers and therefore often have concomitant heart and lung disease. This puts them at increased risk
for the development of postoperative complications, including
permanent respiratory disability and death. Therefore, the
functional assessment of their cardiorespiratory reserves is
very important. This assessment has recently undergone major
changes; apart from preoperative measurement of pulmonary
function (FEV1, diffusing capacity of the lungs for carbon
monoxide [DLCO]), exercise testing with the determination of
maximal oxygen uptake (
O2max) has gained increasing importance. Recently the emphasis has shifted to the prediction of postoperative function (predicted postoperative = ppo).
The parameter, most firmly established, is the FEV1-ppo, but
also DLCO-ppo (1), and most recently
O2max-ppo (3) have
been suggested.
Despite increasing enthusiasm for exercise testing and split
function studies, one has to remember that many patients undergoing lung resections up to pneumonectomy do not need
extensive tests for the assessment of their cardiorespiratory
reserves. We therefore developed an algorithm for the preoperative functional evaluation (Figure 1) incorporating the cardiac history including an electrocardiogram (ECG), and the
three parameters FEV1, DLCO, and
CO2max with their ppo
values. The choice of these parameters of cardiorespiratory function and their respective cutoff values for operability were based on our previous investigations as described in METHODS
(3, 4), and on the recent literature (1, 5).
|
The goal of the current study was to prospectively assess the impact of this algorithm on postoperative morbidity and mortality in a consecutive series of lung resection candidates scheduled for standard thoracotomy. The validation of the algorithm was done by comparing the postoperative complication rates with the ones obtained in our previous series (4) and with other reports in the literature.
| |
METHODS |
|---|
|
|
|---|
Study Population
All patients enrolled in this study were referred to the Respiratory Division of our hospital for investigation and treatment of suspected or proven lung cancer. A total of 137 consecutive patients (102 males and 35 females) with resectable pulmonary lesions scheduled for lung resection by thoracotomy underwent functional assessment between January 1993 and September 1996.
Algorithm
The following algorithm was used in the preoperative functional evaluation (Figure 1): Any patient with active or suspected cardiac disease
had first to undergo a thorough cardiac workup and if necessary even
cardiac bypass surgery in case of ischemic heart disease. Only patients
whose cardiac condition was amenable to treatment could undergo
further investigation for pulmonary resection. Patients who had a negative cardiac history (including a normal ECG) and whose FEV1 and
DLCO were both
80% of predicted normal could undergo lung resection up to a pneumonectomy without any further tests. The cutoff
values of 80% of predicted were chosen because the respective postoperative values are usually > 40% of predicted
identified as safe
(1, 2)
even after pneumonectomy as the diseased lung generally contributes < 50% of the total lung function (8). If either FEV1 or DLCO
was < 80% of predicted, exercise testing with the measurement of
O2max was performed. If
O2max was > 75% of predicted (4) or
> 20 ml/kg/min (5, 6), patients again qualified for resection up to
pneumonectomy. A
O2max < 10 ml/kg/min (3, 6) or < 40% of predicted (4) was generally considered prohibitive for any resection. All
patients with
O2max values in between, that is 40 to 75% of predicted as well as 10 to 20 ml/kg/min, underwent split function studies
to determine the ppo values for FEV1, DLCO, and
O2max. For the
calculation of the remaining pulmonary function for each of these
three parameters, the fractional contribution of the lung tissue to be
resected with curative intent was deducted from overall preoperative
lung function. This calculation was based on lung perfusion scans (see
also SPLIT FUNCTION STUDIES).
If both FEV1-ppo and DLCO-ppo were < 40% of predicted the patient was deemed inoperable (1, 2); if either one or both was
40% of
predicted,
O2max-ppo became the decisive factor. Patients with a
O2max-ppo of < 10ml/kg/min as well as < 40% of predicted were
deemed inoperable (3); if it was either
40% of predicted or
10 ml/
kg/min, the patient was deemed operable up to the calculated extent
of resection.
Pulmonary Function Tests
Pulmonary function tests (PFT) were performed while the patient was at rest in a seated upright position. These tests consisted of spirometry and body plethysmography using the Masterlab (Jäger, Würzburg, Germany). The measurement of the flow-volume loops was recorded according to American Thoracic Society (ATS) criteria (9). Of all recorded parameters the following two were used for the assessment of operability: the best expiratory volume in the first second (FEV1) and DLCO. In patients with obstructive airflow limitation, the PFT were repeated after 1 to 2 wk of intensive bronchodilator therapy including a steroid trial, and the best performance of each patient was used.
The term "percent predicted" used throughout the article refers to the relationship of the value obtained to the normal value for the patient's sex, age, and height. The term "postoperative predicted" refers to the value predicted for the patient after operation and can be expressed in absolute or in percentage of predicted values.
Exercise Testing
If either FEV1 or DLCO was < 80% of predicted, symptom-limited cycle ergometry was performed according to our algorithm (cycle: ER
900 L, Jäger; cardiopulmonary stress testing unit: EOS Sprint, Jäger).
Baseline measurements were recorded after a minimal resting period
of 3 min on the bicycle. The patients then started exercising at constant speed (60 rpm). After a 2 min warm-up period at 20 watts a ramp
protocol with a 20 watt per minute workload increase was started. The
exercise test was stopped when the patients were exhausted, a plateau
in
O2 uptake appeared or at any signs (ECG) or symptoms of myocardial ischemia, including a fall in blood pressure. All parameters
were recorded until the end of a 6-min recovery period. Continuous
measurements of ventilation (
E), oxygen consumption (
O2), carbon dioxide production (VCO2), and pulse rate were averaged every 15 sec. Blood pressure was measured manually (Riva-Rocci) every
minute. A precordial ECG (equivalent leads V1, II, and V5) was monitored continuously (Cardiotest EK 53 R; Hellige, Freiburg, Germany) and hard copies written at rest, at peak exercise, at the end of
the recovery period, and additionally when arrhythmias or changes in
the ST-T segments occurred. Arterial blood samples were drawn from
the radial or brachial artery at rest and at peak exercise and analyzed
immediately. Maximal oxygen consumption was recorded in L/min,
ml/kg/min, and as a percentage of predicted normal values according
to Jones and colleagues (10).
Split Function Studies
Split function studies of regional pulmonary function were performed
while the patient was in a seated upright position and breathing normally at rest. All patients with
O2max values between 10 to 20 ml/kg/
min and 40 to 75% of predicted underwent additional radioisotope
ventilation-perfusion studies to estimate the postoperative FEV1
(FEV1-ppo) according to the method described by Markos and coworkers (1). Using the perfusion lung scans (technetium-99m-labeled macroaggregates), we calculated the fractional contribution of the
lung tissue to be resected to overall lung function. Thereby the following formulas were used: pneumonectomy: postoperative FEV1
(FEV1-ppo) = preoperative FEV1 × (1
fractional contribution of
the affected lung); lobectomy: postoperative FEV1 (FEV1-ppo) = preoperative FEV1 × (1
lobar fractional contribution). The same
technique was used to predict the postoperative diffusion capacity
(DLCO-ppo) (1) and the postoperative exercise capacity (
O2max-ppo) (3). Calculations were made both for absolute and for percentage of predicted values of FEV1-ppo, DLCO-ppo, and
O2max-ppo.
For FEV1-ppo and DLCO-ppo only the percentage of predicted values
were used in the algorithm.
Surgical Procedures, Postoperative Care, and Complications
All pulmonary resections from wedge resection to pneumonectomy were performed with an open thoracotomy; the same team of four thoracic surgeons performed all operations. All patients received standardized anticoagulant therapy with low-molecular-weight heparin (3,000 IU subcutaneously/day) perioperatively. After the operation all patients were admitted to the intensive care unit (ICU) for the first postoperative night. They were extubated either in the theater at the end of the operation or in the ICU within 2 to 4 h. If no complications occurred the patients were transferred to a normal thoracic surgery ward not later than 24 h postoperatively. The duration of hospital stay was calculated as 1 d prior to surgery until discharge. The decision to transfer a patient from the ICU to the normal ward and from there to discharge him or her from hospital was taken by the anesthetists and the thoracic surgeons respectively according to their clinical assessment. The postoperative period (30 d) was recorded for complications as defined in Table 1. Only moderate and severe complications expected to occur as a result of poor cardiopulmonary reserve were included in the list. For comparison's sake it contained the same criteria that were used in our previous reports (3, 4) and in some important earlier studies (1, 5, 6).
|
Statistical Analysis
The comparison of all variables between the current and our previous study results was made with the use of the chi-square test for categorical variables, and Student's t test for continuous variables. A significance level of p < 0.05 was chosen.
Functional Assessment in Our Previous Series
The equipment and test analyses for PFT, exercise testing, and split function studies were identical in our previous (4) and in the current study. The number of investigations per patient, however, differed between the two studies. In the previous series all patients underwent PFT and exercise testing; further, all patients with either an FEV1 < 2 L or a DLCO < 50% underwent additional radioisotope ventilation-perfusion studies to estimate the postoperative FEV1 and DLCO. All patients who were able to perform all investigations then underwent pulmonary resection irrespective of the functional test results. This was essential to analyze each test parameter for its predictive value of postoperative complications, and for the elaboration of cutoff values for safe resection.
| |
RESULTS |
|---|
|
|
|---|
Functional Evaluation
Six (4%) of the 137 patients (Figure 1) underwent first a thorough cardiac workup because of known or suspected cardiac
disease; four of them were deemed operable from a cardiac
point of view after radionuclide heart studies had ruled out active disease and confirmed a normal left ventricular ejection
fraction (LVEF). Two were considered inoperable as their
cardiac condition was not controllable by medical or surgical
treatment. Sixty-seven patients (49%) who had a negative cardiac history (including a normal ECG) and whose FEV1 and
DLCO were both
80% were deemed operable for resections
up to a pneumonectomy without any further testing.
The remaining 68 patients underwent a symptom-limited cycle ergometry; thereafter 51 patients (37% of the initial 137, 75% of the 68) qualified for resection up to a pneumonectomy. Two patients with sufficient PFT reserves (italic numbers in Figure 1) showed marked ischemic ECG changes occurring during maximal exercise. One of them had known coronary artery disease and previous aortic valve replacement. A subsequent radionuclide ventriculography showed a stunned area but normal LVEF; he was therefore deemed operable but died of pneumonia and consecutive multiple organ failure 9 d after a left upper lobectomy. The second patient underwent coronary angiography, which revealed serious three-vessel disease; he underwent coronary artery bypass surgery, and subsequently a lobectomy with an uncomplicated postoperative course.
Seventeen patients (12%) with
O2max values between
10-20 ml/kg/min underwent split function studies to determine their ppo function according to our algorithm. In eight
patients postoperative predicted lung function parameters
were good enough for pneumonectomy; six patients could undergo resection up to a lobectomy only. In three patients the
O2max-ppo was < 10 ml/kg/min as well as < 40%, therefore
they were deemed inoperable (Patients 1, 2, and 5 of Table 2).
|
Thus, of the consecutive group of 137 lung resection candidates, who were functionally assessed with our algorithm, five
patients (4%)
all with lung cancer
were deemed inoperable because of inadequate cardiopulmonary functional reserve
(Table 2). Two of these five patients would have been scheduled for pneumonectomy, three for lobectomy. The parameters for which they were excluded from surgery are indicated
in italic in Table 2. Two patients (Patients 1 and 2) had sufficient pulmonary function results, but very poor cardiopulmonary
reserves reflecting a marginal cardiac output (low
O2max-ppo, and low LVEF on echocardiography). Three were excluded because of poor pulmonary function results (Patients 3-5); two of these three patients were unable to perform the
exercise test, one of them would also have been excluded because of a low
O2max (Patient 5). The 1-yr follow-up of the
spontaneous course of four of these five patients was complicated by recurring episodes of either acute respiratory failure
or of congestive heart failure which necessitated hospitalization in each case; the respiratory failures were not directly tumor-related, but resulted from an exacerbation of the patient's chronic obstructive pulmonary disease (COPD). One
patient had an uneventful course up to 1 yr after radiotherapy.
Procedures
Finally, 132 patients were considered operable and underwent lung resection by thoracotomy. The mean age was 62 yr (range 23 to 81). The baseline characteristics are summarized in Table 3; they were comparable to the ones obtained in our previous study group (4) (no differences on Student's t test). There were 99 (75%) men and 33 (25%) women. The majority of patients (n = 123) had clinically resectable malignancies whereas a few had benign disorders (n = 3) or carcinoid tumors (n = 6). The operations performed were 38 pneumonectomies, 3 bilobectomies, 82 lobectomies, and 9 segmental or wedge resections. There were no operative deaths. All patients were extubated within 24 h.
|
Postoperative Course
One hundred seventeen patients had an uneventful postoperative course. Postoperative complications (within 30 d) occurred in 15 patients (11%), of whom two died, which reflects
an overall mortality rate of 1.5%. Of the 15 patients with complications, four had undergone a pneumonectomy, 10 patients
a lobectomy, and one patient a segmental resection. No patient died after pneumonectomy, bilobectomy, or a resection
of less than a lobe; the mortality of lobectomies was 2.5% (2 of
82). The two patients who died had a
O2max-ppo of < 10 ml/
kg/min (7.5 and 8.2 ml/kg/min respectively), but > 40% of predicted (41 and 46%). Both had undergone a lobectomy; one
died of intractable respiratory failure and the other one of
pneumonia and multiple organ failure. The complications are summarized in Table 4. In comparison with our previous study (4) the complication rate was reduced by 49% (from 20 to
11%) and the mortality decreased from 3.8 to 1.5% (Table 5).
Neither of these decreases reached statistical significance.
|
|
All but three survivors were discharged by Day 30. In two patients the postoperative period was complicated by pulmonary embolism and in one patient by prolonged air leak. The mean stay in the ICU was 1.4 d (SD 1.8) and the total hospital stay 14.6 d (SD 5).
| |
DISCUSSION |
|---|
|
|
|---|
We tested in a prospective study the feasibility of an algorithm
established for the functional evaluation of lung resection candidates. The results showed that adherence to the cutoff
points of the various parameters reduced the postoperative
complications
morbidity and mortality
by half (49%) in
comparison to our previous series (4). This improvement was
statistically not significant because of the low number of complications, especially the low mortality rate. Clinically, however, we consider a decrease in mortality from 3.8% to 1.5%
very relevant, as it is very hard to lower an already low figure
further while extending the limits of operability at the same
time. An overall morbidity of 11% with a mortality of 1.5%
compares favorably with most of the larger published series. Two large studies show even lower mortality than ours; Miller (11) had an overall mortality of 0.64% in a large series of 2,340 patients. Their mortality for pneumonectomy was 4.97%, for lobectomies 0.39%, for wedge resections 0.13, and for exploratory thoracotomies 0.59%. These excellent results may have
been achieved, in part, through fairly rigorous patient selection, as for a pneumonectomy the FEV1 had to be > 2 L and
the FEV1-ppo > 1 L. Another very low mortality rate of 0.9%
was reported by Kearney and coworkers in a series of 331 patients (7). The bulk of the literature shows that there is a clear
correlation between the extent of resection and postoperative
morbidity and mortality. Segmental or wedge resections have
the lowest and pneumonectomies the highest risk (1, 4, 11).
In a large series by Loddenkemper comprising 433 patients,
the mortality rates after pneumonectomy were 9.4% and after
lobectomy 5% (12). In Markos's study the rates were 16.7%
and 0% (1). At our institution an early series had respective rates of 7 and 4% for the years 1972-1978 (13), and 10 and
2.2% for the years 1991-1992 (4). In recent years, the mortality rates after lung resection have generally decreased although the limits of operability have been extended. In our
opinion, these results have been achieved through better functional evaluation before lung resection, but also through improved perioperative care.
The two patients who died after a lobectomy in our study
were known high-risk candidates with borderline operability.
These two patients, as well as the three patients in our previous study (3) who died, all had an absolute
O2max-ppo value
of < 10 ml/kg/min. We therefore slightly amended our algorithm in excluding patients with an absolute
O2max-ppo
value of < 10 ml/kg/min, even if their percentage of predicted
value was > 40%. On the other hand, we could lower the percentage of predicted
O2max-ppo value from 40% to 35%, as
some patients had survived resections with values between
35-40% of predicted, provided that the absolute value was
10 ml/kg/min. In practice, this change makes it more difficult for elderly patients to qualify for operation. With this alteration we theoretically should have obtained a zero mortality without increasing the exclusion rate. Since the introduction of the amended algorithm in late 1996 (Figure 2 [15]), no patient has died from cardiorespiratory complications.
|
A very low mortality rate might of course reflect too rigorous patient selection. In our current study only 5 (4%) of all evaluated patients were deemed functionally inoperable, similar to 5% in the previous one (4). Further, all of these five patients were carefully followed up, and with the spontaneously occurring acute episodes of acute respiratory failure in three and congestive heart failure in one patient, it is probably fair to speculate that the stress of a lobectomy or pneumonectomy might have been fatal to them. We therefore think that the introduction of our algorithm did not unnecessarily exclude patients from surgery. The comparison with our previous study should be largely unbiased, as the baseline patient data were comparable to the current study, and the surgical team and technique as well as the perioperative management were identical. Thus the better outcome reflects the impact of the algorithm.
An important aspect is the cost involved in the preoperative investigation. Half of all patients had a negative cardiac
history, a normal ECG, and an FEV1 and DLCO of
80% of
predicted and thus qualified for a resection of up to a pneumonectomy without further investigations. Another 51 of the
remaining 68 also qualified for a resection up to that extent after exercise testing. Thus 118 (86%) patients were potentially
operable for a pneumonectomy after noninvasive cardiopulmonary testing. The need for radionuclide studies was reduced to 17 (12%) patients only. In our institution, exercise
testing is about 20% cheaper than a radionuclide study and
can be conducted in the pulmonary function laboratory. We therefore prefer to use it before radionuclide studies. This is in
contrast to algorithms proposed by Bechard (16) and Nakahara and colleagues (17), where radionuclide studies are done
before exercise testing. Overall, we think that our algorithm is
economical especially when taking into account the spared
costs due to the improved complication rates. Video-assisted
thoracoscopic surgery (VATS) has been reported to be associated with lower complication rates than open thoracotomy
(18), and might therefore help in further lowering the threshold of functional operability. Whether VATS can provide adequate intraoperative cancer staging is uncertain. Therefore,
this procedure cannot become established as routine practice
for lung cancer surgery as long as long-term survival rates are
not available.
The latest development in the field of thoracic surgery is
lung volume reduction surgery (LVRS) to improve pulmonary
function in patients with severe emphysema (19). Such patients
deemed inoperable according to our algorithm
might
become eligible again through a combination of LVRS and simultaneous cancer surgery. First reports by Gonzalez Munoz
and coworkers (20), Cooper and coworkers (21), and McKenna and coworkers (22) have shown the feasibility of this
approach by removing functionally poor "target zones" of the
lung with LVRS and simultaneously pulmonary nodules
which were either within or outside these target zones. Some
of these nodules were stage I lung cancer, which were mostly removed by wedge resection. With this new concept the limits
of functional operability will potentially be taken another step further. It must be emphasized, however, that most of the reported patients (22, 23) had been scheduled for LVRS and
their cancers were chance discoveries on preoperative computed tomographic (CT) scans; patients who primarily present
with lung cancer and are secondarily found to be functionally
inoperable may have more advanced cancer, which might be
less amenable to minimal resections. The long-term follow-up
will therefore have to carefully assess whether sublobar resections, which have been shown to be fraught with clearly higher
local recurrence rates (24), will remain feasible in such patients. One good argument in favor of limited resections is that
"functionally inoperable" patients might have a better outcome in terms of pulmonary function and even survival when
offered LVRS with limited resection in comparison with a nonsurgical treatment modality, such as radiotherapy, chemotherapy, or just best supportive care.
In summary, our results have shown that adherence to our algorithm for preoperative functional evaluation before lung resection reduced morbidity and mortality by half without unnecessarily excluding patients from surgery. For patients with normal or only slightly abnormal PFT (FEV1 and DLCO) and a negative cardiac history, lung resections up to a pneumonectomy are clearly feasible without exercise or split function studies.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Chris T. Bolliger, Respiratory Division, Department of Internal Medicine, University Hospital, Petersgraben 4, 4031 Basel, Switzerland. E-mail: bolligerct{at}ubaclu.unibas.ch
(Received in original form September 22, 1998 and in revised form December 14, 1998).
| |
References |
|---|
|
|
|---|
1. Markos, J., B. P. Mullan, D. R. Hillman, A. W. Musk, V. F. Antico, F. T. Lovegrove, M. J. Carter, and K. E. Finucane. 1989. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am. Rev. Respir. Dis. 139: 902-910 [Medline].
2. Pierce, R. J., J. M. Copland, K. Sharpe, and C. E. Barter. 1994. Preoperative risk evaluation for lung cancer resections: predicted postoperative product as a predictor of surgical mortality. Am. Rev. Respir. Dis. 150: 947-551 .
3.
Bolliger, C. T.,
C. Wyser,
H. Roser,
M. Solèr, and
A. P. Perruchoud.
1995.
Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for
complications.
Chest
108:
341-348
4. Bolliger, C. T., P. Jordan, M. Solèr, P. Stulz, E. Grädel, K. Skarvan, S. Elsasser, M. Gonon, C. Wyser, M. Tamm, and A. P. Perruchoud. 1995. Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am. J. Respir. Crit. Care Med. 151: 1472-1480 [Abstract].
5. Smith, T. P., G. T. Kinasewitz, W. Y. Tucker, W. P. Spillers, and R. B. George. 1984. Exercise capacity as a predictor of post-thoracotomy morbidity. Am. Rev. Respir. Dis. 129: 730-734 [Medline].
6. Bechard, D., and L. Wetstein. 1987. Assessment of exercise oxygen consumption as preoperative criterion for lung resection. Ann. Thorac. Surg. 44: 344-349 [Abstract].
7.
Kearney, D. J.,
T. H. Lee,
J. J. Reilly,
M. M. DeCamp, and
D. J. Sugarbaker.
1994.
Assessment of operative risk in patients undergoing lung
resection: importance of predicted pulmonary function.
Chest
105:
753-759
8.
Hall, D. R..
1974.
Regional lung function after pneumonectomy.
Thorax
29:
425-431
9.
American Thoracic Society.
1987.
Standardization of spirometry
1987
update.
Am. Rev. Respir. Dis.
136:
1285-1298
[Medline].
10. Jones, N. L., and E. J. M. Campbell. 1982. Clinical Exercise Testing, 2nd ed. W.B. Saunders, Philadelphia.
11. Miller, J. I.. 1993. Physiologic evaluation of pulmonary function in the candidate for lung resection. J. Thorac. Cardiovasc. Surg. 105: 347-352 [Abstract].
12. Loddenkemper, R. 1983. Funktionelle Operabilität beim Bronchialkarzinom: Prospektive Studie zur Einschätzung des Operationsrisikos und der postoperativen Lungenfunktion. Freie Universität Berlin, Habil.-Schrift.
13. Hasse, J. 1986. Surgical treatment of Bronchial Carcinoma. Springer-Verlag, Berlin, Heidelberg.
14.
Melendez, J. A., and
V. A. Carlon.
1998.
Cardiopulmonary risk index
does not predict complications after thoracic surgery.
Chest
114:
69-75
15.
Bolliger, C. T., and
A. P. Perruchoud.
1998.
Functional evaluation of the
lung resection candidate.
Eur. Respir. J.
11:
198-212
16. Bechard, D. E. 1992. Pulmonary function testing. In J. LoCicero III, editor. Diagnostic Procedures for Thoracic Diseases. W. B. Saunders, Philadelphia.
17. Nakahara, K., S. Miyoshi, and K. Nakagawa. 1992. A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer. Ann. Thorac. Surg. 54: 1016-1017 [Medline].
18. Walker, W. S., F. M. Carnochan, and G. C. Pugh. 1993. Thoracoscopic pulmonary lobectomy. J. Thorac. Cardiovasc. Surg. 106: 1111-1117 [Abstract].
19.
Cooper, J. D.,
E. P. Trulock,
A. N. Triantafillou,
G. A. Patterson,
M. S. Pohl,
P. A. Deloney,
R. S. Sundaresan, and
C. L. Roper.
1995.
Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease.
J. Thorac. Cardiovasc. Surg.
109:
106-119
20. Gonzalez Munoz, J. I., M. Cordoba Pelaez, M. J. Ferreiro Alvarez, P. Ussetti Gi, and A. Varela de Ugarte. 1996. Lung volume reduction surgery: new expectations in the surgical treatment of lung cancer. Chest 109: 1664 .
21.
Cooper, J. D.,
G. A. Patterson,
S. R. DeMeester,
R. D. Yusen, and
S. S. Lefrak.
1996.
Lobectomy combined with lung volume reduction for
high risk lung cancer patients with severe emphysema.
Chest
110:
49S
22.
McKenna, R. J.,
R. J. Fischel,
M. Brenner, and
A. F. Gelb.
1996.
Combined operations for lung volume reduction surgery and lung cancer.
Chest
110:
885-888
23.
Ojo, T. C.,
F. Martinez,
R. Paine III,
P. J. Christensen,
J. L. Curtis,
J. G. Weg,
E. A. Kazerooni, and
R. Whyte.
1997.
Lung volume reduction
surgery alters management of pulmonary nodules in patients with severe COPD.
Chest
112:
1494-1500
24.
Ginsberg, R.,
L. Rubenstein, and
the Lung Cancer Study Group.
1995.
Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer.
Ann. Thorac. Surg.
60:
615-623
This article has been cited by other articles:
![]() |
A. Brunelli, A. Charloux, C. T. Bolliger, G. Rocco, J-P. Sculier, G. Varela, M. Licker, M. K. Ferguson, C. Faivre-Finn, R. M. Huber, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Eur. Respir. J., July 1, 2009; 34(1): 17 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. B. van Tilburg, H. Stam, H. C. Hoogsteden, and R. J. van Klaveren Pre-operative pulmonary evaluation of lung cancer patients: a review of the literature Eur. Respir. J., May 1, 2009; 33(5): 1206 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Melloul, B. Egger, T. Krueger, C. Cheng, F. Mithieux, C. Ruffieux, L. Magnusson, and H.-B. Ris Mortality, complications and loss of pulmonary function after pneumonectomy vs. sleeve lobectomy in patients younger and older than 70 years Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 986 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Luzzi, S. Tenconi, L. Voltolini, P. Paladini, C. Ghiribelli, M. Di Bisceglie, and G. Gotti Long-term respiratory functional results after pneumonectomy. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 164 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Colice, S. Shafazand, J. P. Griffin, R. Keenan, and C. T. Bolliger Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 161S - 177S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ohno, H. Koyama, M. Nogami, D. Takenaka, S. Matsumoto, M. Yoshimura, Y. Kotani, and K. Sugimura Postoperative Lung Function in Lung Cancer Patients: Comparative Analysis of Predictive Capability of MRI, CT, and SPECT Am. J. Roentgenol., August 1, 2007; 189(2): 400 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Mineo, O. Schillaci, E. Pompeo, D. Mineo, and G. Simonetti Usefulness of Lung Perfusion Scintigraphy Before Lung Cancer Resection in Patients with Ventilatory Obstruction Ann. Thorac. Surg., November 1, 2006; 82(5): 1828 - 1834. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gould and A. Pearce Assessment of suitability for lung resection CEACCP, June 1, 2006; 6(3): 97 - 100. [Full Text] [PDF] |
||||
![]() |
M. J. Licker, I. Widikker, J. Robert, J.-G. Frey, A. Spiliopoulos, C. Ellenberger, A. Schweizer, and J.-M. Tschopp Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann. Thorac. Surg., May 1, 2006; 81(5): 1830 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ohno, H. Hatabu, T. Higashino, M. Nogami, D. Takenaka, H. Watanabe, M. Van Cauteren, M. Yoshimura, M. Satouchi, Y. Nishimura, et al. Oxygen-enhanced MR Imaging: Correlation with Postsurgical Lung Function in Patients with Lung Cancer Radiology, August 1, 2005; 236(2): 704 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Barrera, W. Shi, D. Amar, H. T. Thaler, N. Gabovich, M. S. Bains, and D. A. White Smoking and Timing of Cessation: Impact on Pulmonary Complications After Thoracotomy Chest, June 1, 2005; 127(6): 1977 - 1983. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ohno, H. Hatabu, T. Higashino, D. Takenaka, H. Watanabe, Y. Nishimura, M. Yoshimura, and K. Sugimura Dynamic Perfusion MRI Versus Perfusion Scintigraphy: Prediction of Postoperative Lung Function in Patients with Lung Cancer Am. J. Roentgenol., January 1, 2004; 182(1): 73 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Datta and B. Lahiri Preoperative Evaluation of Patients Undergoing Lung Resection Surgery Chest, June 1, 2003; 123(6): 2096 - 2103. [Abstract] [Full Text] [PDF] |
||||
![]() |
ATS/ACCP Statement on Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277. [Full Text] [PDF] |
||||
![]() |
M. A. Beckles, S. G. Spiro, G. L. Colice, and R. M. Rudd The Physiologic Evaluation of Patients With Lung Cancer Being Considered for Resectional Surgery Chest, January 1, 2003; 123 (2009): 105S - 114S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Wu, H.-B. Pan, A. A. Chiang, H.-K. Hsu, H.-C. Chang, N.-J. Peng, P.-H. Lai, H.-L. Liang, and C.-F. Yang Prediction of Postoperative Lung Function in Patients with Lung Cancer: Comparison of Quantitative CT with Perfusion Scintigraphy Am. J. Roentgenol., March 1, 2002; 178(3): 667 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beccaria, A. Corsico, P. Fulgoni, M. C. Zoia, L. Casali, G. Orlandoni, and I. Cerveri Lung Cancer Resection : The Prediction of Postsurgical Outcomes Should Include Long-term Functional Results Chest, July 1, 2001; 120(1): 37 - 42. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |